The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cyclophosphamide (Cy) pharmacogenetics (PGx) in allogeneic stem cell transplant (SCT) patients (pts) receiving Cy, fludarabine, total body irradiation and post-transplant Cy (FluCyTBI-postCy).
 
Jai Narendra Patel
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Janssen Research & Development (Inst)
 
Qing Zhang
Patents, Royalties, Other Intellectual Property - Have patents related with disease diagnosis and prognosis (Inst)
 
Issam Hamadeh
No Relationships to Disclose
 
Nury Steuerwald
No Relationships to Disclose
 
Alicia Hamilton
No Relationships to Disclose
 
Jonathan Michael Gerber
Research Funding - Janssen Research & Development (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No. 9,012,215; U.S. Track One Patent Application No. 15/796,201
 
Michael Richard Grunwald
Stock and Other Ownership Interests - Medtronic
Honoraria - Imedex; TotalCME
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; ARIAD; Cardinal Health; Celgene; Incyte; Pfizer
Research Funding - Amgen (Inst); FORMA Therapeutics (Inst); Genentech/Roche (Inst); Incyte (Inst); Janssen (Inst)
 
Lawrence Druhan
No Relationships to Disclose
 
Jiaxian He
No Relationships to Disclose
 
Belinda Rene Avalos
No Relationships to Disclose
 
Edward Alan Copelan
No Relationships to Disclose